0001614811-19-000002.txt : 20191226 0001614811-19-000002.hdr.sgml : 20191226 20191223185113 ACCESSION NUMBER: 0001614811-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191224 DATE AS OF CHANGE: 20191223 EFFECTIVENESS DATE: 20191224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lakewood-Amedex, Inc. CENTRAL INDEX KEY: 0001614811 IRS NUMBER: 205274304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-356373 FILM NUMBER: 191307664 BUSINESS ADDRESS: STREET 1: 7267 DELAINEY COURT CITY: SARASOTA STATE: FL ZIP: 34240 BUSINESS PHONE: (941) 225-2515 MAIL ADDRESS: STREET 1: 7267 DELAINEY COURT CITY: SARASOTA STATE: FL ZIP: 34240 D 1 primary_doc.xml X0708 D LIVE 0001614811 Lakewood-Amedex, Inc. 3030 University Parkway SARASOTA FL FLORIDA 34243-2502 (941) 225-2515 DELAWARE None None Corporation true Steven Parkinson 7004 Stanhope Place University Park FL FLORIDA 34201 Executive Officer Director Mr. Parkinson is the President and Chief Executive Officer of the Corporation and is on the Board of Directors of the Corporation Patrick Coleman O'Connor 6300 Thorndon Circle University Park FL FLORIDA 34201 Executive Officer Dr. O'Connor is the Chief Medical Officer of the corporation Peter Ceccacci 3030 University Parkway Attention: Peter Ceccacci Sarasota FL FLORIDA 34243 Executive Officer Mr. Ceccacci is the Corporate Controller of the corporation Geoffrey Frank Cox 637 South Owl Drive Sarasota FL FLORIDA 34236 Director Leonard James DeRoma 50 Cove Road Huntington NY NEW YORK 11743 Director Charles Frederick Wright 38 Valencia Street Saint Augustine FL FLORIDA 32084 Director Pharmaceuticals No Revenues 06b false 2019-04-12 false true false 100000 Sargasso Consulting LLC None None None Crawford House, 4th Floor, 50 Cedar Aven Hamilton D0 BERMUDA HM 11 true 15000000 456000 14544000 Three existing investors invested in April. At that time, issuer anticipated limited offering to existing investors under Sec. 4(a)(2) w/o Form D filing. Issuer then received interest from personal contacts and was advised to file. No sales made since May false 3 12000 true 0 Current fee is paid as an engagement fee. Additional fees may be due for consulting, advisory functions, and investor relations on an ongoing basis. 0 false Lakewood-Amedex, Inc. Steven Parkinson Steven Parkinson President and Chief Executive Officer 2019-12-23